Immunitybio Correlations
IBRX Stock | USD 5.04 0.06 1.18% |
The current 90-days correlation between Immunitybio and Lexicon Pharmaceuticals is 0.03 (i.e., Significant diversification). The correlation of Immunitybio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Immunitybio Correlation With Market
Average diversification
The correlation between Immunitybio and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunitybio and DJI in the same portfolio, assuming nothing else is changed.
Immunitybio |
Moving together with Immunitybio Stock
0.66 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
0.66 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.7 | GILD | Gilead Sciences | PairCorr |
0.65 | MNMD | Mind Medicine | PairCorr |
0.75 | CPRX | Catalyst Pharmaceuticals | PairCorr |
Moving against Immunitybio Stock
0.84 | ZTS | Zoetis Inc | PairCorr |
0.78 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.77 | TAK | Takeda Pharmaceutical | PairCorr |
0.75 | HLN | Haleon plc | PairCorr |
0.72 | LLY | Eli Lilly | PairCorr |
0.72 | RDY | Dr Reddys Laboratories | PairCorr |
0.69 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.68 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.55 | ELAN | Elanco Animal Health | PairCorr |
0.89 | ANRO | Alto Neuroscience, | PairCorr |
0.58 | CTLT | Catalent | PairCorr |
0.54 | AMGN | Amgen Inc | PairCorr |
0.54 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.5 | LTRN | Lantern Pharma | PairCorr |
0.43 | CVS | CVS Health Corp Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immunitybio Stock performing well and Immunitybio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunitybio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BLRX | 3.98 | (0.98) | 0.00 | 2.42 | 0.00 | 4.88 | 59.21 | |||
ARDX | 2.99 | (0.29) | 0.00 | (0.02) | 0.00 | 5.02 | 33.99 | |||
LXRX | 3.69 | (1.07) | 0.00 | (0.84) | 0.00 | 6.70 | 46.58 | |||
MCRB | 4.93 | 0.32 | 0.04 | 1.12 | 5.57 | 10.84 | 28.84 | |||
EFTR | 7.57 | (4.57) | 0.00 | (470.75) | 0.00 | 8.70 | 88.91 | |||
PLX | 3.13 | 1.12 | 0.28 | (1.37) | 2.37 | 10.00 | 20.38 | |||
PDSB | 3.34 | (0.65) | 0.00 | (0.27) | 0.00 | 7.67 | 31.83 | |||
LIFE | 2.57 | 0.38 | 0.09 | 2.06 | 2.62 | 6.45 | 28.98 | |||
ELEV | 3.51 | (0.48) | 0.00 | (0.11) | 0.00 | 5.77 | 22.21 |
Immunitybio Corporate Management
Jason JD | General Secretary | Profile | |
Sandeep MD | Chief Officer | Profile | |
Helen Luu | Chief Officer | Profile | |
Leonard MD | Chief Officer | Profile | |
Jason Liljestrom | General Secretary | Profile | |
Barry MD | Chief Director | Profile |